Date of response: 13 August 2025

Outcome: Information partially disclosed

Category: Joint Commissioning and Planned Care

Request

NICE funding variation for tirzepatide (Mounjaro) for the management of obesity

ICB Response

NN ICB 25 1256 Response Letter Final

pdf (121K)

Close
Search